US Stock MarketDetailed Quotes

Processa Pharmaceuticals (PCSA)

Watchlist
  • 2.765
  • +0.055+2.03%
Close Apr 21 16:00 ET
  • 2.740
  • -0.025-0.90%
Pre 07:04 ET
7.36MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Processa Pharmaceuticals (PCSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
16.08%13.99M
35.37%3.7M
1.87%3.49M
28.19%3.95M
1.33%2.85M
5.19%12.05M
10.74%2.73M
58.00%3.42M
13.54%3.08M
-31.57%2.81M
Selling and administrative expenses
29.19%6.18M
55.36%1.59M
60.66%1.83M
11.24%1.5M
-0.95%1.26M
-15.47%4.78M
-11.01%1.02M
11.96%1.14M
31.69%1.35M
-48.73%1.27M
-General and administrative expense
29.19%6.18M
55.36%1.59M
60.66%1.83M
11.24%1.5M
-0.95%1.26M
-15.47%4.78M
-11.01%1.02M
11.96%1.14M
31.69%1.35M
-48.73%1.27M
Research and development costs
7.45%7.81M
23.43%2.11M
-27.36%1.66M
41.43%2.45M
3.21%1.59M
25.34%7.27M
29.66%1.71M
98.61%2.29M
2.50%1.73M
-5.43%1.54M
Operating profit
-16.08%-13.99M
-35.37%-3.7M
-1.87%-3.49M
-28.19%-3.95M
-1.33%-2.85M
-5.19%-12.05M
-10.74%-2.73M
-58.00%-3.42M
-13.54%-3.08M
31.57%-2.81M
Net non-operating interest income expense
-45.55%109.49K
482.97%35.49K
30.00%52K
-84.88%12.59K
-40.07%201.09K
-90.56%6.09K
-53.30%40K
-0.29%83.22K
Non-operating interest income
-45.55%109.49K
482.97%35.49K
30.00%52K
----
-84.88%12.59K
-40.07%201.09K
-90.56%6.09K
-53.30%40K
----
-0.29%83.22K
Other net income (expense)
315.18K
307.46K
80.00%270
-76.48%16.87K
150
-29.64%71.7K
Gain on sale of security
--295.18K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
--20K
--12.28K
80.00%270
-76.48%16.87K
----
----
----
--150
-29.64%71.7K
----
Income before tax
-14.46%-13.56M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
Income tax
0
0
Net income
-14.46%-13.56M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
Net income continuous Operations
-14.46%-13.56M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
Minority interest income
Net income attributable to the parent company
-14.46%-13.56M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.46%-13.56M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
Basic earnings per share
89.30%-10.36
92.95%-1.306
93.20%-1.75
75.25%-6.25
72.97%-7.5
54.35%-96.78
55.62%-18.53
33.12%-25.75
47.94%-25.25
68.56%-27.75
Diluted earnings per share
89.30%-10.36
92.95%-1.306
93.20%-1.75
75.25%-6.25
72.97%-7.5
54.35%-96.78
55.62%-18.53
33.12%-25.75
47.94%-25.25
68.56%-27.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 16.08%13.99M35.37%3.7M1.87%3.49M28.19%3.95M1.33%2.85M5.19%12.05M10.74%2.73M58.00%3.42M13.54%3.08M-31.57%2.81M
Selling and administrative expenses 29.19%6.18M55.36%1.59M60.66%1.83M11.24%1.5M-0.95%1.26M-15.47%4.78M-11.01%1.02M11.96%1.14M31.69%1.35M-48.73%1.27M
-General and administrative expense 29.19%6.18M55.36%1.59M60.66%1.83M11.24%1.5M-0.95%1.26M-15.47%4.78M-11.01%1.02M11.96%1.14M31.69%1.35M-48.73%1.27M
Research and development costs 7.45%7.81M23.43%2.11M-27.36%1.66M41.43%2.45M3.21%1.59M25.34%7.27M29.66%1.71M98.61%2.29M2.50%1.73M-5.43%1.54M
Operating profit -16.08%-13.99M-35.37%-3.7M-1.87%-3.49M-28.19%-3.95M-1.33%-2.85M-5.19%-12.05M-10.74%-2.73M-58.00%-3.42M-13.54%-3.08M31.57%-2.81M
Net non-operating interest income expense -45.55%109.49K482.97%35.49K30.00%52K-84.88%12.59K-40.07%201.09K-90.56%6.09K-53.30%40K-0.29%83.22K
Non-operating interest income -45.55%109.49K482.97%35.49K30.00%52K-----84.88%12.59K-40.07%201.09K-90.56%6.09K-53.30%40K-----0.29%83.22K
Other net income (expense) 315.18K307.46K80.00%270-76.48%16.87K150-29.64%71.7K
Gain on sale of security --295.18K------------------------------------
Other non- operating income (expenses) --20K--12.28K80.00%270-76.48%16.87K--------------150-29.64%71.7K----
Income before tax -14.46%-13.56M-23.10%-3.36M-1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M
Income tax 00
Net income -14.46%-13.56M-23.10%-3.36M-1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M
Net income continuous Operations -14.46%-13.56M-23.10%-3.36M-1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M
Minority interest income
Net income attributable to the parent company -14.46%-13.56M-23.10%-3.36M-1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.46%-13.56M-23.10%-3.36M-1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M
Basic earnings per share 89.30%-10.3692.95%-1.30693.20%-1.7575.25%-6.2572.97%-7.554.35%-96.7855.62%-18.5333.12%-25.7547.94%-25.2568.56%-27.75
Diluted earnings per share 89.30%-10.3692.95%-1.30693.20%-1.7575.25%-6.2572.97%-7.554.35%-96.7855.62%-18.5333.12%-25.7547.94%-25.2568.56%-27.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.00%
Sample Name
Sample Code
 +12.85%
Sample Name
Sample Code
 +9.97%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+9.57%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.29%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +34.94%
Sample Name
Sample Code
 +28.57%
Sample Name
Sample Code
 +11.29%
4
ASE Technology
ASX
+10.16%
5
Pony AI
PONY
+7.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 21 EST, Iran's Tasnim News Agency reported that Iran had ultimately decided not to attend the talks scheduled for Wednesday, April Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -